DOCSLIB.ORG

Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor–Mediated Signaling

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor–Mediated Signaling Research Article Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor–Mediated Signaling Elona Bic¸aku, Douglas C. Marchion, Morgen L. Schmitt, and Pamela N. Mu¨nster Department of Interdisciplinary Oncology, Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Abstract and LBH589, convey tamoxifen sensitivity to the ER-negative cell line, MDA-231, by inducing the release of HDAC1 from the ERa Several histone deacetylases (HDAC) are involved in estrogen a receptor (ER)–mediated gene transactivation, and HDAC promoter, thus restoring ER expression (3, 4) or the activation of ERh, as suggested by others (5). In ER-positive cell lines, HDAC inhibitors have been reported to restore sensitivity to a antihormonal therapy. The modulation of ER is the most inhibitors have been shown to repress ER expression (6, 7) and sensitize cells to tamoxifen (5, 8), which may involve the up- promising approach to ER-expressing breast cancers. Recent h studies further suggest a critical role of the progesterone regulation or translocation of ER (9, 10). Although these studies receptor (PR) on ER signaling. Although HDAC inhibitors suggest a benefit of adding an HDAC inhibitor to antiestrogen modulate ER, little is known about their effects on PR. We therapy, the differential effects on ERsuggest that the modulation of ERmay not entirely explain the synergy between HDAC evaluated the roles of specific HDAC isoenzymes and their inhibition on both ER and PR signaling and their importance inhibitors and antiestrogen therapy. in response to endocrine therapy. The roles of individual About 70% of women with breast cancer present with tumors HDAC isoenzymes on ER and PR expression and their that express ERand the majority of those coexpress progesterone functions were evaluated by depletion of select HDAC enzymes receptor (PR; ref. 11). Most of the currently used antihormonal using siRNA or pharmacologic inhibition. Cotreatment of therapies predominantly target ER. Antiprogestins and other breast cancer cell lines with HDAC inhibitors and the modalities targeting PRare now rarely used, not due to inefficacy antiestrogen, tamoxifen, resulted in synergistic antitumor but due to undesirable side effects such as profound weight gain activity with simultaneous depletion of both ER and PR. (12, 13). Although it seems that the coexpression of PRin patients, Selective inhibition of HDAC2, but not HDAC1 or HDAC6, whose tumors express ER, predicts a better outcome, the role of PRas a predictive factor for antihormone therapy remains under was sufficient to potentiate tamoxifen-induced apoptosis in ER/PR-positive cells. Depletion of HDAC1 and HDAC6 was debate (14–16). Furthermore, there are very few reported associated with down-regulation of ER but not PR. Only the modalities to address the potential benefits of simultaneous selective depletion of HDAC2 siRNA down-regulated both ER down-regulation of ERand PR,or the predictive value of the and PR expression, and was sufficient to potentiate tamoxifen. pharmacologic modulation of PRin addition to ER.Although PR Selective depletion of HDAC2 resulted in simultaneous levels are induced by ER, PR may become hormone independent depletion of ER and PR, and potentiated the effects of upon transformation to a more aggressive phenotype (17–19). antihormonal therapy in ER-positive cells. A more effective The role of PRas a target for endocrine therapy is still under debate pharmacologic inhibition of HDAC2 and evaluation of HDAC2 and very little is known about the interaction between HDAC and PR as therapeutic targets or as predictive markers in enzymes and PR. hormonal therapy may be considered when combining HDAC In this study, we show that the selective inhibition of HDAC2 by inhibitors and hormonal therapy. [Cancer Res 2008;68(5):1513–9] siRNAresulted in simultaneous depletion of ERas well as PRand potentiated the antitumor effects of tamoxifen in ER-positive cell lines. Introduction Histone acetyl-transferases and histone deacetylases (HDAC) Materials and Methods play a crucial role in gene regulation. Specific interference with histone acetylation and methylation by drugs has shown to be Chemicals and antibodies. Valproic acid was purchased from Sigma- Aldrich. Vorinostat (suberoylanilide hydroxamic acid) was provided by Aton promising in the treatment and prevention of cancer. Several Pharma. 4-OH-Hydroxytamoxifen (tamoxifen) and MS-275 were purchased reports suggest a potential role of HDACs and their inhibitors in from Calbiochem. ERa, PR, and HER2-neu–directed antibodies were breast cancer. A direct interaction of HDAC1 and estrogen receptor purchased from Santa Cruz Biotechnology, Inc. HDAC1 and HDAC2 (ER) may be involved in the response to antiestrogen therapy antibodies were purchased from Upstate Biotechnology. HDAC6 was (1). Experimental overexpression of HDAC1 was associated with purchased from Santa Cruz Biotechnology, Inc. Glyceraldehyde-3-phosphate repression of ERin MCF-7 cells and reactivation of ERupon dehydrogenase antibody was purchased from Chemicon. exposure to the HDAC inhibitor, trichostatin A (TSA; ref. 2). Further Cell lines. All cell lines were purchased from the American Type Culture reports suggest that the hydroxamic acid HDAC inhibitors, TSA Collection and maintained in DMEM (Fisher Scientific) with 10% heat- inactivated fetal bovine serum (Sigma-Aldrich), 2 mmol/L glutamine, and 50 unit/mL penicillin and 50 Ag/mL streptomycin (Fisher Scientific). Cells were incubated in a humidified atmosphere with 5% CO2 at 37jC. Requests for reprints: Pamela N. Mu¨nster, H. Lee Moffitt Cancer Center, 12901 Microarray. Alterations in gene expression induced by valproic acid and Magnolia Drive, SRC 22007, Tampa, FL 33612. Phone: 813-745-8948; Fax: 813-745-1984; vorinostat were evaluated by microarray using Affymetrix U133-plus E-mail: [email protected]. I2008 American Association for Cancer Research. 2.0 Genechips by standard protocols (H. Lee Moffitt Cancer Center and doi:10.1158/0008-5472.CAN-07-2822 Research Institute, Bill and Beverly Young National Functional Genomics www.aacrjournals.org 1513 Cancer Res 2008; 68: (5). March 1, 2008 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 2008 American Association for Cancer Research. Cancer Research Figure 1. HDAC inhibitors synergize with tamoxifen in breast cancer cell lines. A, differential expression of HDAC1, 2 and 6, ER, and HER2 in a limited breast cancer cell line panel by Western blot analysis. B, treatment of breast cancer cell lines with different levels of ERand HER2expression with tamoxifen ( tam)inthe presence of the HDAC inhibitor, valproic acid (VPA), resulted in increased cell death compared with tamoxifen alone by MTS assays and potentiation of tamoxifen-induced apoptosis in MCF-7 cells (C) treated for 48 h with three different classes of HDAC inhibitors (MS-275, 2 Amol/L; vorinostat, 1 Amol/L; or valproic acid, 2 mmol/L) either alone or in combination with tamoxifen (10 Amol/L). Center), with duplicate samples for each condition run on separate 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo- Genechips. Hybridization to Affymetrix chips was analyzed using Affymetrix phenyl)2H-tetrazolium, inner salt assay. Equal numbers of cells (1 Â 104 Microarray Suite 5.0 software. Signal intensity was scaled to an average cells per well for MCF-7, T-47D, and SKBr-3; 5 Â 103 cells per well for intensity of 500 before comparison analysis. The MAS 5.0 software uses a MDA-231) were cultured in 96-well plates, followed by a 24-hour incubation statistical algorithm to assess increases or decreases in mRNA abundance at 37jC, 5% CO2. Cells were then incubated with 2 mmol/L valproic acid, in a direct comparison between two samples (Statistical Algorithms 10 Amol/L tamoxifen, or the combination for 48 h and evaluated for description document).1 proliferation using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy- SiRNA. RNA duplexes for HDAC1, HDAC2, and HDAC6 were purchased phenyl)-2-(4-sulfophenyl)2H-tetrazolium, inner salt (MTS) assay (Promega). from Ambion. Cells were transfected by electroporation using the Western blot analysis. Cells were harvested in tissue culture medium Nucleofector transfection kit according to manufacturer’s recommenda- using a Cell Lifter, washed in PBS, and solubilized using SDS lysis buffer tions (Amaxa). Cells (4 Â 106) were suspended in 0.1 mL electroporation [2% SDS, 10% glycerol, and 0.06 mol/L Tris (pH 6.8)]. The protein buffer containing 1 Amol/L siRNA and pulsed with a cell line–specific concentration of the SDS lysates was determined by the bicinchoninic acid protocol as described by the manufacturer. Pulsed cells were resuspended method (Pierce). Proteins (50 Ag) were separated on 8% SDS-PAGE gels and in 0.5 mL complete medium without antibiotics and incubated at 37jCfor transferred to nitrocellulose membranes. Membranes were blocked in tris- 15 min before experimentation. The Silencer Negative Control #2 siRNA buffered saline containing 0.05% Tween 20 (TBST), 5% nonfat milk; and (Ambion), a nonsense siRNA duplex, was used as a control. incubated with primary antibody in TBST, 5% nonfat milk, overnight at Apoptosis assay. Cells (5 Â 105) were treated with drugs (MS-275, 4jC. Membranes were washed thrice for 10 min with TBST and incubated 1 Amol/L; vorinostat, 1 Amol/L; valproic acid, 2 mmol/L; tamoxifen, with the appropriate secondary antibody in TBST, 5% nonfat milk for 10 Amol/L; or combination) for 48 h. Cells were harvested in medium using 60 min at room temperature. Antibody binding was visualized by chemi- a Cell Lifter (Fisher Scientific) and washed in PBS. Cell nuclei were stained luminescence on autoradiography film. with 0.5 Ag/mL bis-benzimide (Hoechst 33258). Apoptosis was scored by the presence of nuclear chromatin condensation and DNA fragmentation, Results and evaluated by fluorescence microscopy. Two hundred cells were counted per experiment in at least six different fields and scored for apoptosis HDAC inhibitors potentiate the antiestrogen, tamoxifen, (apoptotic nuclei/all nuclei Â100).
Load more

Recommended publications
  • Interplay Between Epigenetics and Metabolism in Oncogenesis: Mechanisms and Therapeutic Approaches
    OPEN Oncogene (2017) 36, 3359–3374 www.nature.com/onc REVIEW Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches CC Wong1, Y Qian2,3 and J Yu1 Epigenetic and metabolic alterations in cancer cells are highly intertwined. Oncogene-driven metabolic rewiring modifies the epigenetic landscape via modulating the activities of DNA and histone modification enzymes at the metabolite level. Conversely, epigenetic mechanisms regulate the expression of metabolic genes, thereby altering the metabolome. Epigenetic-metabolomic interplay has a critical role in tumourigenesis by coordinately sustaining cell proliferation, metastasis and pluripotency. Understanding the link between epigenetics and metabolism could unravel novel molecular targets, whose intervention may lead to improvements in cancer treatment. In this review, we summarized the recent discoveries linking epigenetics and metabolism and their underlying roles in tumorigenesis; and highlighted the promising molecular targets, with an update on the development of small molecule or biologic inhibitors against these abnormalities in cancer. Oncogene (2017) 36, 3359–3374; doi:10.1038/onc.2016.485; published online 16 January 2017 INTRODUCTION metabolic genes have also been identified as driver genes It has been appreciated since the early days of cancer research mutated in some cancers, such as isocitrate dehydrogenase 1 16 17 that the metabolic profiles of tumor cells differ significantly from and 2 (IDH1/2) in gliomas and acute myeloid leukemia (AML), 18 normal cells. Cancer cells have high metabolic demands and they succinate dehydrogenase (SDH) in paragangliomas and fuma- utilize nutrients with an altered metabolic program to support rate hydratase (FH) in hereditary leiomyomatosis and renal cell 19 their high proliferative rates and adapt to the hostile tumor cancer (HLRCC).
    [Show full text]
  • The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc Oncogenesis
    The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis By Yuting Sun This thesis is submitted in fulfilment of the requirements for the degree of Doctor of Philosophy at the University of New South Wales Children’s Cancer Institute Australia for Medical Research School of Women’s and Children’s Health, Faculty of Medicine University of New South Wales Australia August 2014 PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Sun First name: Yuting Other name/s: Abbreviation for degree as given in the University calendar: PhD School : School of·Women's and Children's Health Faculty: Faculty of Medicine Title: The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis. Abstract 350 words maximum: (PLEASE TYPE) N-Myc Induces neuroblastoma by regulating the expression of target genes and proteins, and N-Myc protein is degraded by Fbxw7 and NEDD4 and stabilized by Aurora A. The class lla histone deacetylase HDAC5 suppresses gene transcription, and blocks myoblast and leukaemia cell differentiation. While histone H3 lysine 4 (H3K4) trimethylation at target gene promoters is a pre-requisite for Myc· induced transcriptional activation, WDRS, as a histone H3K4 methyltransferase presenter, is required for H3K4 methylation and transcriptional activation mediated by a histone H3K4 methyltransferase complex. Here, I investigated the roles of HDAC5 and WDR5 in N-Myc overexpressing neuroblastoma. I have found that N-Myc upregulates HDAC5 protein expression, and that HDAC5 represses NEDD4 gene expression, increases Aurora A gene expression and consequently upregulates N-Myc protein expression in neuroblastoma cells.
    [Show full text]
  • The Histone Deacetylase HDA15 Interacts with MAC3A and MAC3B to Regulate Intron
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.386672; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 The histone deacetylase HDA15 interacts with MAC3A and MAC3B to regulate intron 2 retention of ABA-responsive genes 3 4 Yi-Tsung Tu1#, Chia-Yang Chen1#, Yi-Sui Huang1, Ming-Ren Yen2, Jo-Wei Allison Hsieh2,3, 5 Pao-Yang Chen2,3*and Keqiang Wu1* 6 7 1Institute of Plant Biology, National Taiwan University, Taipei 10617, Taiwan 8 2 Institute of Plant and Microbial Biology, Academia Sinica, Taipei 11529, Taiwan 9 3 Genome and Systems Biology Degree Program, Academia Sinica and National Taiwan 10 University, Taipei, Taiwan 11 12 # These authors contributed equally to this work. 13 * Corresponding authors: Keqiang Wu ([email protected], +886-2-3366-4546) and Pao-Yang 14 Chen ([email protected], +886-2-2787-1140) 15 16 Short title: HDA15 and MAC3A/MAC3B coregulate intron retention 17 One sentence summary: HDA15 and MAC3A/MAC3B coregulate intron retention and reduce 18 the histone acetylation level of the genomic regions near ABA-responsive retained introns. 19 20 The author responsible for distribution of materials integral to the findings presented in this 21 article in accordance with the policy described in the Instructions for Authors (www.plantcell.org) 22 is: Keqiang Wu ([email protected]) 23 24 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.386672; this version posted November 17, 2020.
    [Show full text]
  • Determining HDAC8 Substrate Specificity by Noah Ariel Wolfson A
    Determining HDAC8 substrate specificity by Noah Ariel Wolfson A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Biological Chemistry) in the University of Michigan 2014 Doctoral Committee: Professor Carol A. Fierke, Chair Professor Robert S. Fuller Professor Anna K. Mapp Associate Professor Patrick J. O’Brien Associate Professor Raymond C. Trievel Dedication My thesis is dedicated to all my family, mentors, and friends who made getting to this point possible. ii Table of Contents Dedication ....................................................................................................................................... ii List of Figures .............................................................................................................................. viii List of Tables .................................................................................................................................. x List of Appendices ......................................................................................................................... xi Abstract ......................................................................................................................................... xii Chapter 1 HDAC8 substrates: Histones and beyond ...................................................................... 1 Overview ..................................................................................................................................... 1 HDAC introduction
    [Show full text]
  • Distinct Contributions of DNA Methylation and Histone Acetylation to the Genomic Occupancy of Transcription Factors
    Downloaded from genome.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Research Distinct contributions of DNA methylation and histone acetylation to the genomic occupancy of transcription factors Martin Cusack,1 Hamish W. King,2 Paolo Spingardi,1 Benedikt M. Kessler,3 Robert J. Klose,2 and Skirmantas Kriaucionis1 1Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, United Kingdom; 2Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, United Kingdom; 3Target Discovery Institute, University of Oxford, Oxford, OX3 7FZ, United Kingdom Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are often governed by multilayered structure, how individual pathways contribute to gene expression remains poorly under- stood. For example, DNA methylation is known to regulate transcription factor binding but also to recruit methyl-CpG binding proteins that affect chromatin structure through the activity of histone deacetylase complexes (HDACs). Both of these mechanisms can potentially affect gene expression, but the importance of each, and whether these activities are inte- grated to achieve appropriate gene regulation, remains largely unknown. To address this important question, we measured gene expression, chromatin accessibility, and transcription factor occupancy in wild-type or DNA methylation-deficient mouse embryonic stem cells following HDAC inhibition. We observe widespread increases in chromatin accessibility at ret- rotransposons when HDACs are inhibited, and this is magnified when cells also lack DNA methylation. A subset of these elements has elevated binding of the YY1 and GABPA transcription factors and increased expression. The pronounced ad- ditive effect of HDAC inhibition in DNA methylation–deficient cells demonstrates that DNA methylation and histone deacetylation act largely independently to suppress transcription factor binding and gene expression.
    [Show full text]
  • Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
    cancers Review Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy Mohammed I. Y. Elmallah 1,2,* and Olivier Micheau 1,* 1 INSERM, Université Bourgogne Franche-Comté, LNC UMR1231, F-21079 Dijon, France 2 Chemistry Department, Faculty of Science, Helwan University, Ain Helwan 11795 Cairo, Egypt * Correspondence: [email protected] (M.I.Y.E.); [email protected] (O.M.) Received: 23 May 2019; Accepted: 18 June 2019; Published: 19 June 2019 Abstract: One of the main characteristics of carcinogenesis relies on genetic alterations in DNA and epigenetic changes in histone and non-histone proteins. At the chromatin level, gene expression is tightly controlled by DNA methyl transferases, histone acetyltransferases (HATs), histone deacetylases (HDACs), and acetyl-binding proteins. In particular, the expression level and function of several tumor suppressor genes, or oncogenes such as c-Myc, p53 or TRAIL, have been found to be regulated by acetylation. For example, HATs are a group of enzymes, which are responsible for the acetylation of histone proteins, resulting in chromatin relaxation and transcriptional activation, whereas HDACs by deacetylating histones lead to chromatin compaction and the subsequent transcriptional repression of tumor suppressor genes. Direct acetylation of suppressor genes or oncogenes can affect their stability or function. Histone deacetylase inhibitors (HDACi) have thus been developed as a promising therapeutic target in oncology. While these inhibitors display anticancer properties in preclinical models, and despite the fact that some of them have been approved by the FDA, HDACi still have limited therapeutic efficacy in clinical terms. Nonetheless, combined with a wide range of structurally and functionally diverse chemical compounds or immune therapies, HDACi have been reported to work in synergy to induce tumor regression.
    [Show full text]
  • Cigarette Smoking-Induced Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Approaches
    Cigarette Smoking-Induced Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Approaches DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Tamer M. Abdelghany Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Dr. Jay L. Zweier, MD, Advisor Dr. Arthur Strauch III, PhD Dr. Amal Amer, MD PhD Copyright by Tamer M. Abdelghany 2013 Abstract Cigarette smoking (CS) remains the single largest preventable cause of death. Worldwide, smoking causes more than five million deaths annually and, according to the current trends, smoking may cause up to 10 million annual deaths by 2030. In the U.S. alone, approximately half a million adults die from smoking-related illnesses each year which represents ~ 19% of all deaths in the U.S., and among them 50,000 are killed due to exposure to secondhand smoke (SHS). Smoking is a major risk factor for cardiovascular disease (CVD). The crucial event of The CVD is the endothelial dysfunction (ED). Despite of the vast number of studies conducted to address this significant health problem, the exact mechanism by which CS induces ED is not fully understood. The ultimate goal of this thesis; therefore, is to study the mechanisms by which CS induces ED, aiming at the development of new therapeutic strategies that can be used in protection and/or reversal of CS-induced ED. In the first part of this study, we developed a well-characterized animal model for chronic secondhand smoke exposure (SHSE) to study the onset and severity of the disease.
    [Show full text]
  • Antigen-Specific Memory CD4 T Cells Coordinated Changes in DNA
    Downloaded from http://www.jimmunol.org/ by guest on September 24, 2021 is online at: average * The Journal of Immunology The Journal of Immunology published online 18 March 2013 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2013/03/17/jimmun ol.1202267 Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells Shin-ichi Hashimoto, Katsumi Ogoshi, Atsushi Sasaki, Jun Abe, Wei Qu, Yoichiro Nakatani, Budrul Ahsan, Kenshiro Oshima, Francis H. W. Shand, Akio Ametani, Yutaka Suzuki, Shuichi Kaneko, Takashi Wada, Masahira Hattori, Sumio Sugano, Shinichi Morishita and Kouji Matsushima J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Author Choice option Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Freely available online through http://www.jimmunol.org/content/suppl/2013/03/18/jimmunol.120226 7.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Author Choice Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 24, 2021. Published March 18, 2013, doi:10.4049/jimmunol.1202267 The Journal of Immunology Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells Shin-ichi Hashimoto,*,†,‡ Katsumi Ogoshi,* Atsushi Sasaki,† Jun Abe,* Wei Qu,† Yoichiro Nakatani,† Budrul Ahsan,x Kenshiro Oshima,† Francis H.
    [Show full text]
  • Pan-Histone Deacetylase Inhibitors Regulate Signaling Pathways
    Majumdar et al. BMC Genomics 2012, 13:709 http://www.biomedcentral.com/1471-2164/13/709 RESEARCH ARTICLE Open Access Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells Gipsy Majumdar1, Piyatilake Adris1, Neha Bhargava1, Hao Chen2 and Rajendra Raghow1,2* Abstract Background: We have shown previously that pan-HDAC inhibitors (HDACIs) m-carboxycinnamic acid bis-hydroxamide (CBHA) and trichostatin A (TSA) attenuated cardiac hypertrophy in BALB/c mice by inducing hyper-acetylation of cardiac chromatin that was accompanied by suppression of pro-inflammatory gene networks. However, it was not feasible to determine the precise contribution of the myocytes- and non-myocytes to HDACI-induced gene expression in the intact heart. Therefore, the current study was undertaken with a primary goal of elucidating temporal changes in the transcriptomes of cardiac myocytes exposed to CBHA and TSA. Results: We incubated H9c2 cardiac myocytes in growth medium containing either of the two HDACIs for 6h and 24h and analyzed changes in gene expression using Illumina microarrays. H9c2 cells exposed to TSA for 6h and 24h led to differential expression of 468 and 231 genes, respectively. In contrast, cardiac myocytes incubated with CBHA for 6h and 24h elicited differential expression of 768 and 999 genes, respectively. We analyzed CBHA- and TSA-induced differentially expressed genes by Ingenuity Pathway (IPA), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Core_TF programs and discovered that CBHA and TSA impinged on several common gene networks. Thus, both HDACIs induced a repertoire of signaling kinases (PTEN-PI3K-AKT and MAPK) and transcription factors (Myc, p53, NFkB and HNF4A) representing canonical TGFβ, TNF-α, IFNγ and IL-6 specific networks.
    [Show full text]
  • Histone Deacetylase Inhibitors Synergizes with Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
    Author Manuscript Published OnlineFirst on September 19, 2018; DOI: 10.1158/1535-7163.MCT-18-0348 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti- tumor activity in small cell carcinoma of the ovary, hypercalcemic type Yemin Wang1,2,*, Shary Yuting Chen1,2, Shane Colborne3, Galen Lambert2, Chae Young Shin2, Nancy Dos Santos4, Krystal A. Orlando5, Jessica D. Lang6, William P.D. Hendricks6, Marcel B. Bally4, Anthony N. Karnezis1,2, Ralf Hass7, T. Michael Underhill8, Gregg B. Morin3,9, Jeffrey M. Trent6, Bernard E. Weissman5, David G. Huntsman1,2,10,* 1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada 2Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada. 3Michael Smith Genome Science Centre, British Columbia Cancer Agency, Vancouver, BC, Canada. 4Department of Experimental Therapeutics, British Columbia Cancer Research Centre, Vancouver, BC, Canada. 5Department of Pathology and Laboratory Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 6Division of Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA. 7Department of Obstetrics and Gynecology, Hannover Medical School, D-30625 Hannover, Germany. 8Department of Cellular and Physiological Sciences and Biomedical Research Centre, University 1 Downloaded from mct.aacrjournals.org on September 26, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on September 19, 2018; DOI: 10.1158/1535-7163.MCT-18-0348 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Phosphate Availability and Ectomycorrhizal Symbiosis with Pinus Sylvestris Have Independent Effects on the Paxillus Involutus Transcriptome
    This is a repository copy of Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/168854/ Version: Published Version Article: Paparokidou, C., Leake, J.R. orcid.org/0000-0001-8364-7616, Beerling, D.J. et al. (1 more author) (2020) Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome. Mycorrhiza. ISSN 0940- 6360 https://doi.org/10.1007/s00572-020-01001-6 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Mycorrhiza https://doi.org/10.1007/s00572-020-01001-6 ORIGINAL ARTICLE Phosphate availability and ectomycorrhizal symbiosis with Pinus sylvestris have independent effects on the Paxillus involutus transcriptome Christina Paparokidou1 & Jonathan R. Leake1 & David J. Beerling1 & Stephen A. Rolfe1 Received: 16 June 2020 /Accepted: 29 October 2020 # The Author(s) 2020 Abstract Many plant species form symbioses with ectomycorrhizal fungi, which help them forage for limiting nutrients in the soil such as inorganic phosphate (Pi).
    [Show full text]
  • SET-Induced Calcium Signaling and MAPK/ERK Pathway Activation Mediate Dendritic Cell-Like Differentiation of U937 Cells
    Leukemia (2005) 19, 1439–1445 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells A Kandilci1 and GC Grosveld1 1Department of Genetics and Tumor Cell Biology, Mail Stop 331, St Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA Human SET, a target of chromosomal translocation in human G1/S transition by allowing cyclin E–CDK2 activity in the leukemia encodes a highly conserved, ubiquitously expressed, presence of p21.11 Second, SET interacts with cyclin B–CDK1.19 nuclear phosphoprotein. SET mediates many functions includ- ing chromatin remodeling, transcription, apoptosis and cell Overexpression of SET inhibits cyclin B-CDK1 activity, which in cycle control. We report that overexpression of SET directs turn, blocks the G2/M transition; this finding suggests a negative 13 differentiation of the human promonocytic cell line U937 along regulatory role for SET in G2/M transition. Overexpression of the dendritic cell (DC) pathway, as cells display typical cell division autoantigen-1 (CDA1), another member of the morphologic changes associated with DC fate and express NAP/SET family, inhibits proliferation and decreases bromo- the DC surface markers CD11b and CD86. Differentiation occurs deoxyuridine uptake in HeLa cells.20 Acidic and basic domains via a calcium-dependent mechanism involving the CaMKII and 20 MAPK/ERK pathways. Similar responses are elicited by inter- of CDA1 show 40% identity and 68% similarity to SET. feron-c (IFN-c) treatment with the distinction that IFN-c signaling We have recently shown that overexpression of SET in the activates the DNA-binding activity of STAT1 whereas SET human promonocytic cell line U937 causes G0/G1 arrest and overexpression does not.
    [Show full text]